Ridge Preservation Following Tooth Extraction Using Two Mineralized Cancellous Bone Allografts



Status:Completed
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:18 - 89
Updated:1/24/2018
Start Date:September 2015
End Date:September 2017

Use our guide to learn which trials are right for you!

Ridge Preservation Following Tooth Extraction Using Mineralized Freeze-Dried Bone Allograft Compared to PUROS Mineralized Bone Allograft

The study is a 2-arm, parallel-design, randomized, prospective clinical trial designed to
examine histologic wound healing following ridge preservation using bone allograft that has
been prepared by either freeze-drying or via a non-freeze-dried solvent process.This entire
protocol involves procedures that are standard care. All materials are FDA-approved materials
being used in an FDA-approved manner. The test group subjects will have extraction sockets
grafted with a cancellous non-freeze-dried bone allograft (called PUROS graft). This test
group will be compared to an active control group using cancellous freeze-dried bone
allograft (called FDBA). The null hypothesis is that there will be no significant difference
in formation of new vital bone between treatment groups (primary outcome).

Each subject will provide a single non-molar tooth site for study treatment. After tooth
extraction, the graft material will be placed and covered by a resorbable collagen membrane.
Following 3 months of healing, the dental implant will be place, at which time a core of bone
will be removed from the site as part of the preparation for the implant. The core biopsy
will then be evaluated for the primary histologic outcome of % vital bone formation and
secondary histologic outcome of % residual graft material.

The study is designed to examine histologic wound healing following ridge preservation using
cancellous bone allograft that has been prepared either by freeze-drying (FDBA) or by a
solvent-based processing method (PUROS). This entire protocol involves procedures that are
standard care. All materials are FDA-approved materials being used in an FDA-approved manner.
The test group subjects will have extraction sockets grafted with a cancellous
non-freeze-dried bone allograft (called PUROS graft). This test group will be compared to an
active control group using cancellous freeze-dried bone allograft (called FDBA). The null
hypothesis is that there will be no significant difference in formation of new vital bone
between treatment groups (primary outcome).

Each subject will provide a single non-molar tooth site for study treatment. After tooth
extraction, the graft material will be placed and covered by a resorbable collagen membrane.
Following 3 months of healing, the dental implant will be place, at which time a core of bone
will be removed from the site as part of the preparation for the implant. The core biopsy
will then be evaluated for the primary histologic outcome of % vital bone formation and
secondary histologic outcome of % residual graft material.

Inclusion Criteria:Patients will be included in this study if they qualify the following
inclusion criteria:

- Live within 50 miles from the School of Dentistry, University of Texas Health Science
Center at San Antonio

- Are able to attend a minimum of 6 visits over a 4-5 month period, as required by the
study protocol

- A single rooted tooth that has been identified as requiring extraction

- Desire a dental implant to replace the missing tooth

- Have adequate restorative space for a dental implant-retained restoration

- Have at least 10mm of alveolar bone height, without impinging on the maxillary sinus
or inferior alveolar canal.

- Have a dehiscence of the buccal or lingual bony plate of the tooth socket extending no
more than 50% of the total depth of the socket.

- Female patients who have undergone a hysterectomy, tubal ligation, or menopause, and
non-pregnant women of child-bearing potential.

- Are nonsmokers or former smokers. Current smokers may only be included if they smoke
<10 cigarettes per day

Exclusion Criteria:

- Patients who live more than 50 miles from the School of Dentistry, University of Texas
Health Science Center at San Antonio

- Patients who do not meet all the inclusion criteria or who will not cooperate with the
required follow-up schedule.

- Patients will are mentally incompetent, prisoners, or pregnant.

- Pregnant women or women intending to become pregnant during the study period.

- Smokers who smoke >10 cigarettes per day

- Clinical and/or radiographic determinations which will preclude inclusion in this
study are: Active infection other than periodontitis; Inadequate bone dimensions or
restorative space for a dental implant; Presence of a disease entity, condition or
therapeutic regimen which decreases probability of soft tissue and bony healing, e.g.,
poorly controlled diabetes, chemotherapeutic and immunosuppressive agents, autoimmune
diseases, history of bisphosphonate use or long-term steroid therapy; Positive medical
history of endocarditis following oral or dental surgery.

- Sensitivity or allergy to Bacitracin, Gentamicin, Polymyxin B Sulfate, alcohol and/or
surfactants
We found this trial at
1
site
San Antonio, Texas 78229
Phone: 210-567-3318
?
mi
from
San Antonio, TX
Click here to add this to my saved trials